Journal of the National Comprehensive Cancer Network : JNCCN Journal

Overview
Identity
View All

publication venue for

Health Care Lobbying and Oncology.. 22:226-230. 2024
Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.. 22:117-135. 2024
Association Between Alcohol Use Disorder and Hospital Readmission Rates and Outcomes in Cancer Survivors: A Population Cohort Study.. 22. 2024
NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024.. 21:1224-1233. 2023
Predicting All-Cause Mortality in Women With and Without Breast Cancer Using the Schonberg Index: A Women's Health Initiative Study.. 21:636-644.e13. 2023
Association Between Pretreatment Skeletal Muscle and Outcomes After CAR T-Cell Therapy.. 21:373-382.e1. 2023
External Validation of Risk Factors for Unplanned Hospitalization in Older Adults With Advanced Cancer Receiving Chemotherapy.. 21:273-280.e3. 2023
Effect of Yoga and Mediational Influence of Fatigue on Walking, Physical Activity, and Quality of Life Among Cancer Survivors.. 21:153-162.e2. 2023
Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.. 21:181-209. 2023
Association of Polypharmacy and Potentially Inappropriate Medications With Frailty Among Older Adults With Blood Cancers.. 20:915-923.e5. 2022
Associations Between Medicaid Insurance, Biomarker Testing, and Outcomes in Patients With Advanced NSCLC.. 20:479-487.e2. 2022
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.. 20:285-308. 2022
Cancer Treatment During COVID-19: Resilience of Individuals With Advanced Non-Small Cell Lung Cancer Versus Community Controls.. 20:118-125. 2022
Representation and Outcomes of Older Adults in Practice-Changing Oncology Trials in the Era of Novel Therapies: A Guideline Appraisal.. 20:37-44. 2022
NCCN Guidelines® Insights: Older Adult Oncology, Version 1.2021.. 19:1006-1019. 2021
Harmonized Outcome Measures for Use in Non-Small Cell Lung Cancer Patient Registries and Clinical Practice. 2021
NCCN Guidelines® Insights: Palliative Care, Version 2.2021.. 19:780-788. 2021
Bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.. 19:915-921. 2021
Characteristics Associated With Functional Changes During Systemic Cancer Treatments: A Systematic Review Focused on Older Adults.. 19:1055-1062. 2021
Aging Phenotypes and Restoring Functional Deficits in Older Adults With Hematologic Malignancy.. 19:1027-1036. 2021
Association of Polypharmacy and Potentially Inappropriate Medications With Physical Functional Impairments in Older Adults With Cancer.. 19:1-274. 2021
NCCN Guidelines Insights: T-Cell Lymphomas, Version 1.2021.. 18:1460-1467. 2020
Neoadjuvant Immunotherapy-Based Systemic Treatment in MMR-Deficient or MSI-High Rectal Cancer: Case Series.. 18:798-804. 2020
Outcomes of Patients With Cancer Discharged to a Skilled Nursing Facility After Acute Care Hospitalization.. 18:856-865. 2020
Treating Elderly Patients With Muscle-Invasive Bladder Cancer.. 18:783-790. 2020
NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020.. 18:522-536. 2020
Current Practices for Screening and Management of Financial Distress at NCCN Member Institutions.. 18:825-831. 2020
Physician Experience and Risk of Rituximab Discontinuation in Older Adults With Non-Hodgkin's Lymphoma.. 17:1194-1202. 2019
Incorporating Tumor Characteristics to Maximize 21-Gene Assay Utility: A Cost-Effectiveness Analysis.. 17:39-46. 2019
Systematic Review of Randomized Controlled Trials of Exercise Interventions Using Digital Activity Trackers in Patients With Cancer.. 17:57-63. 2019
Use of Inpatient Palliative Care Services in Patients With Advanced Cancer Receiving Critical Care Therapies.. 16:1055-1064. 2018
Adherence to Guidelines for Breast Surveillance in Breast Cancer Survivors.. 16:526-534. 2018
Community Oncologists' Decision-Making for Treatment of Older Patients With Cancer.. 16:301-309. 2018
Apoyo con Cariño: Strategies to Promote Recruiting, Enrolling, and Retaining Latinos in a Cancer Clinical Trial.. 15:1392-1399. 2017
Time to Change: Supporting Sexual and Gender Minority People-An Underserved, Understudied Cancer Risk Population.. 15:1305-1308. 2017
Racial and Ethnic Disparities in Oncotype DX Test Receipt in a Statewide Population-Based Study.. 15:346-354. 2017
Predictors of the Use of Specific Critical Care Therapies in Patients With Metastatic Cancer.. 15:22-30. 2017
Correspondence.. 14:li-lvi. 2016
NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016.. 14:1357-1370. 2016
Associations Between End-of-Life Cancer Care Patterns and Medicare Expenditures.. 14:1001-8. 2016
Predictors of In-Hospital Mortality in Patients With Metastatic Cancer Receiving Specific Critical Care Therapies.. 14:979-87. 2016
Prostate Cancer, Version 1.2016.. 14:19-30. 2016
Databases as Vehicles for Comparative Effectiveness Research.. 13:1585-8. 2015
Anemia and Functional Disability in Older Adults With Cancer.. 13:1233-9. 2015
Geriatric Assessment-Guided Care Processes for Older Adults: A Delphi Consensus of Geriatric Oncology Experts.. 13:1120-30. 2015
Senior adult oncology, version 2.2014: clinical practice guidelines in oncology .. 12:82-126. 2014
Determinants of enrollment in cancer clinical trials: the relationship between the current state of knowledge, societal disease burden, and randomized clinical trial enrollment.. 11:928-36. 2013
Senior adult oncology.. 10:162-209. 2012
Senior adult oncology clinical practice guidelines in oncology.. 3:572-90. 2005